Monitoring T-cell responses in a phase II study of AGS-003, an autologous dendritic cell-based therapy in patients with newly diagnosed advanced stage renal cell carcinoma in combination with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback